Association of hepatosplenic schistosomiasis with HLA-DQB1*0201

Journal of Infectious Diseases

Volumn 174, Issue 5, 1996, Pages 1131-1135

  Evan Secor, W ^a   Del Corral, Helena D ^b   Dos Reis, Mitermayer G ^b   Ramos, Eduardo A G ^b   Zimon, Alison E ^b   Peixoto Matos, E ^b   Reis, Eliana A G ^b   Do Carmo, Theomira M A ^b   Hirayama, Kenji ^b   David, Roberta A ^b   David, John R ^b   Harn Jr , Donald A ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ARTICLE; BRAZIL; GENE FREQUENCY; HLA TYPING; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; PARASITE VIRULENCE; PREVALENCE; PRIORITY JOURNAL; SCHISTOSOMIASIS;

EID: 19244361922     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.5.1131     Document Type: Article

References (15)

1. Cheever AW. A quantitative post-mortem study of Schistosomiasis mansoni in man. Am J Trop Med Hyg 1968;17:38-64.
2. Cook JA, Baker ST, Warren KS, Jordan P. A controlled study of morbidity of Schistosomiasis mansoni in St. Lucian children, based on quantitative egg excretion. Am J Trop Med Hyg 1974;23:625-33.
3. Colley DG, Garcia AA, Lambertucci JR, et al. Immune responses during human Schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg 1986;35:793-802.
4. Hafez M, Aboul Hassan S, el-Tahan H, et al. Immunogenetic susceptibility for post-schistosomal hepatic fibrosis. Am J Trop Med Hyg 1991;44:424-33.
5. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-5.
6. Dunne DW, Butterworth AE, Fulford AJC, et al. Immunity after treatment of human Schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-94.
7. Cheever AW, Williams ME, Wynn TA, et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994;153:753-9.
8. Wynn TA, Cheever AW, Jankovic D, et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995;372:594-6.
9. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, proceedings of the 11th International Histocompatibility Workshop and Conference. Vol 1. Oxford, UK: Oxford University Press, 1992;397-419.
10. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 1987;327:426-30.
11. Homeida M, Ahmed S, Dafalla A, et al. Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 1988;39:196-201.
12. Bassily S, Dunn MA, Farid Z, et al. Chronic hepatitis B in patients with schistosomiasis mansoni. J Trop Med Hyg 1983;86:67-71.
13. Salam EA, Ishaac S, Mahmoud AA. Histocompatibilty-linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni. J Immunol 1979;123:1829-31.
14. Ohta N, Hayashi M, Tormis LC, Blas BL, Nosenas JS, Sasazuki T. Immunogenetic factors involved in the pathogenesis of distinct clinical manifestations of schistosomiasis japonica in the Philippine population. Trans R Soc Trop Med Hyg 1987;81:292-6.
15. Wishahi M, el-Baz HG, Shaker ZA. Association between HLA-A, B, C and DR antigens and clinical manifestations of Schistosoma haematobium in the bladder. Eur Urol 1989;16:138-43.